Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone-Iodine Intranasal for COVID-19 Prophylaxis
NCT04364802Phase 2Completed
- Start
- Apr 2020
- Primary completion
- Jan 2022
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of IVIEW-1502 in coronavirus disease 2019 (COVID-19). Started Apr 2020; status: completed.
02
Drugs
IVIEW-1502
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04364802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04364802.